Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
Saved in:
| Title: | Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response |
|---|---|
| Authors: | Yhim, Ho-Young1, Lee, Na-Ri1,2, Song, Eun-Kee1,2, Yim, Chang-Yeol1,2, Jeon, So Yeon1, Shin, Seunghwan3, Kim, Jeong-A3, Kim, Hee Sun4, Cho, Eun Hae5, Kwak, Jae-Yong1,2 jykwak@jbnu.ac.kr |
| Source: | Leukemia Research. Jun2012, Vol. 36 Issue 6, p689-693. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01452126 |
|---|---|
| DOI: | 10.1016/j.leukres.2012.02.011 |
